Literature DB >> 19846525

Hepatitis C virus-linked mitochondrial dysfunction promotes hypoxia-inducible factor 1 alpha-mediated glycolytic adaptation.

Maria Ripoli1, Annamaria D'Aprile, Giovanni Quarato, Magdalena Sarasin-Filipowicz, Jérôme Gouttenoire, Rosella Scrima, Olga Cela, Domenico Boffoli, Markus H Heim, Darius Moradpour, Nazzareno Capitanio, Claudia Piccoli.   

Abstract

Hepatitis C virus (HCV) infection induces a state of oxidative stress by affecting mitochondrial-respiratory-chain activity. By using cell lines inducibly expressing different HCV constructs, we showed previously that viral-protein expression leads to severe impairment of mitochondrial oxidative phosphorylation and to major reliance on nonoxidative glucose metabolism. However, the bioenergetic competence of the induced cells was not compromised, indicating an efficient prosurvival adaptive response. Here, we show that HCV protein expression activates hypoxia-inducible factor 1 (HIF-1) by normoxic stabilization of its alpha subunit. In consequence, expression of HIF-controlled genes, including those coding for glycolytic enzymes, was significantly upregulated. Similar expression of HIF-controlled genes was observed in cell lines inducibly expressing subgenomic HCV constructs encoding either structural or nonstructural viral proteins. Stabilization and transcriptional activation of HIF-1alpha was confirmed in Huh-7.5 cells harboring cell culture-derived infectious HCV and in liver biopsy specimens from patients with chronic hepatitis C. The HCV-related HIF-1alpha stabilization was insensitive to antioxidant treatment. Mimicking an impairment of mitochondrial oxidative phosphorylation by treatment of inducible cell lines with oligomycin resulted in stabilization of HIF-1alpha. Similar results were obtained by treatment with pyruvate, indicating that accumulation of intermediate metabolites is sufficient to stabilize HIF-1alpha. These observations provide new insights into the pathogenesis of chronic hepatitis C and, possibly, the HCV-related development of hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19846525      PMCID: PMC2798449          DOI: 10.1128/JVI.00769-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA.

Authors:  A A Kolykhalov; E V Agapov; K J Blight; K Mihalik; S M Feinstone; C M Rice
Journal:  Science       Date:  1997-07-25       Impact factor: 47.728

2.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

Review 3.  Angiogenesis and hepatocellular carcinoma.

Authors:  David Semela; Jean-François Dufour
Journal:  J Hepatol       Date:  2004-11       Impact factor: 25.083

Review 4.  The redox regulation of PI 3-kinase-dependent signaling.

Authors:  Nick R Leslie
Journal:  Antioxid Redox Signal       Date:  2006 Sep-Oct       Impact factor: 8.401

Review 5.  Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators.

Authors:  Marc-André C Déry; Maude D Michaud; Darren E Richard
Journal:  Int J Biochem Cell Biol       Date:  2005-03       Impact factor: 5.085

6.  Hepatitis C virus, ER stress, and oxidative stress.

Authors:  Keith D Tardif; Gulam Waris; Aleem Siddiqui
Journal:  Trends Microbiol       Date:  2005-04       Impact factor: 17.079

Review 7.  Reactive oxygen species in tumor progression.

Authors:  Peter Storz
Journal:  Front Biosci       Date:  2005-05-01

8.  Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.

Authors:  K Tanimoto; Y Makino; T Pereira; L Poellinger
Journal:  EMBO J       Date:  2000-08-15       Impact factor: 11.598

Review 9.  HCV infection induces mitochondrial bioenergetic unbalance: causes and effects.

Authors:  C Piccoli; G Quarato; M Ripoli; A D'Aprile; R Scrima; O Cela; D Boffoli; D Moradpour; N Capitanio
Journal:  Biochim Biophys Acta       Date:  2008-11-27

10.  Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins.

Authors:  D Moradpour; P Kary; C M Rice; H E Blum
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

View more
  72 in total

Review 1.  Immunometabolism: Cellular Metabolism Turns Immune Regulator.

Authors:  Róisín M Loftus; David K Finlay
Journal:  J Biol Chem       Date:  2015-11-03       Impact factor: 5.157

Review 2.  Reprogramming of cellular metabolic pathways by human oncogenic viruses.

Authors:  John G Purdy; Micah A Luftig
Journal:  Curr Opin Virol       Date:  2019-11-22       Impact factor: 7.090

Review 3.  Long noncoding RNAs in the metabolic control of inflammation and immune disorders.

Authors:  Junfang Xu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2018-05-23       Impact factor: 11.530

4.  mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function.

Authors:  Raymond P Donnelly; Róisín M Loftus; Sinéad E Keating; Kevin T Liou; Christine A Biron; Clair M Gardiner; David K Finlay
Journal:  J Immunol       Date:  2014-09-26       Impact factor: 5.422

5.  The influence of macrophage growth factors on Theiler's Murine Encephalomyelitis Virus (TMEV) infection and activation of macrophages.

Authors:  Karin M Schneider; Neva B Watson; Scott B Minchenberg; Paul T Massa
Journal:  Cytokine       Date:  2017-08-09       Impact factor: 3.861

Review 6.  Viral activation of cellular metabolism.

Authors:  Erica L Sanchez; Michael Lagunoff
Journal:  Virology       Date:  2015-03-23       Impact factor: 3.616

7.  Functional implications of mitochondrial reactive oxygen species generated by oncogenic viruses.

Authors:  Young Bong Choi; Edward William Harhaj
Journal:  Front Biol (Beijing)       Date:  2014-12

Review 8.  Metabolic regulation of immune responses: therapeutic opportunities.

Authors:  Nadine Assmann; David K Finlay
Journal:  J Clin Invest       Date:  2016-06-01       Impact factor: 14.808

9.  Vitamin D Metabolites Inhibit Hepatitis C Virus and Modulate Cellular Gene Expression.

Authors:  Julio A Gutierrez; Krysten A Jones; Roxana Flores; Akul Singhania; Christopher H Woelk; Robert T Schooley; David L Wyles
Journal:  J Virol Antivir Res       Date:  2014-10-06

Review 10.  Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma.

Authors:  Alla Arzumanyan; Helena M G P V Reis; Mark A Feitelson
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.